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ARTICLE 
ARE WE BULLETPROOF?: 
A DEFENSIVE BUSINESS STRATEGY TO PROTECT 
HEALTH CARE COMPANIES FROM FALSE CLAIMS ACT 
LITIGATION AND CORPORATE INTEGRITY 
AGREEMENTS 
By: Jim Moye* 
"The days ofscamming dollars from our health care system are 
over. Thanks to new tools contained in the Affordable Care Act, 
we are more prepared than ever to safeguard taxpayer dollars 
and ensure that the health care coverage of our seniors, families 
and children is secure.,,[I] 
H ealth care fraud has become a hot topic in corporate America. In Fiscal Year 2007, an estimated $2.26 trillion was spent on health 
care in this country. 2 All governments, but especially the United States 
government, stepped up efforts to combat fraud, abuse, and waste in the 
health care system. In 2009 alone, the Department of Justice, in 
conjunction with other federal agencies, filed 800 indictments, obtained 
over 600 convictions, and recouped over $3 billion in health care fraud 
cases prosecuted through the False Claims Act.3 The Federal Bureau of 
Investigations claimed it investigated over 2,400 cases of health care 
* B.A., 1995, University of Southern California; J.D., 1999, The Catholic University of 
America, Columbus School of Law. The author would like to thank Kamina Pinder, Esq., 
Professor, The John Marshall School of Law, for her assistance and support. Additionally, the 
author would like to thank Professors George P. Smith, II and Leroy D. Clark (emeritus) of 
The Catholic University of America, Columbus School of Law for their guidance and advice 
while he was in law school. Comments and suggestions may be sent to 
jim.r.moye@gmail.com. 
I See HHS Secretary Sebilius, u.s. Attorney General Holder Kick Off First Regional 
Health Care Fraud Prevention Summit in Miami, Florida, DRUG WK., Aug. 6,2010, at 247, 
2010 WLNR 15084270 at 247 (2010). 
2 See Beth Fitzgerald, Insurer Sniffs Out Fraud Amid Soaring Health Care Costs, N.J. 
BIZ, Sept. 6, 2010, at 5, available at 2010 WLNR 19029436. 
3 Press Release, U.S Dep't of Justice, Attorney Gen. Eric Holder speaks at the 2010 
BenchlBar Conference in PA, (Sept. 17,2010) available at http://www.justice.gov. ("In 
addition, through a new partnership with the Department of Health and Human Services, 
we've brought the full resources of the federal government to bear against those who illegally 
divert taxpayer resources from government-funded healthcare programs. Last year, the 
Department filed more than 800 indictments, and obtained nearly 600 convictions, for health 
care fraud-related charges. And, over the past 20 months, the Department has recouped close 
to $3 billion in health care fraud cases through use of the False Claims Act."). 
24 
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fraud in one year.4 In July 2010, the Department of Justice announced 
arguably the largest health care fraud sting in history when it brought 
charges against 94 people, located in five different states.5 The 
government charged that the case involved $251 million in Medicare 
payments for services that were either medically unnecessary or never 
performed.6 One piece of the case, worth an alleged $70 million, took 
place in New York and alleged over 1,000 cash "kickbacks" were paid to 
Medicare beneficiaries.7 The case implicated doctors, health care 
company owners, and executives.8 
Another noteworthy case involved AstraZeneca. The pharmaceutical 
giant allegedly illegally marketed an anti-psychosis medication for uses 
not deemed safe and effective, also known as "off-labeling.,,9 The 
settlement agreement signed by the company alleged that marketing the 
drug for unapproved purposes caused payment for false claims to 
Medicare, Medicaid, TRICARE programs, the Department of Veterans 
Affairs, the Federal Employee Health Benefits program, and the Bureau 
of Prisons. lo For its perceived transgression, AstraZeneca paid a civil 
fine of $520 million and agreed to a second, five-year Corporate Integrity 
Agreement with the Department of Health and Human Services. II 
Finally, there were lesser allegations that AstraZeneca violated Anti-
Kickback Statutes by making illegal payments to doctors to serve as 
authors for studies already completed by AstraZeneca, paying for doctors 
to lecture on the unapproved uses of the drug and paying doctors to travel 
4 Carrie Johnson, 53 in Detroit and Miami Indicted in Medicare Fraud Sting, WASH. 
POST, June 25,2009, at A03. 
5 See Jerry Markon, 94 Caught in Major Health-Care Fraud Sting, SEA TILE TIMES, July 
17,2010,2010 WLNR 14425674 at A6. 
6 !d. 
7 Id. 
8 [d. 
9 Pharmaceutical Giant AstraZeneca to Pay $520 million for Off-Label Drug Marketing 
for Regulatory Agencies, BIOTECH WK., May 12, 2010, 2010 WLNR 9382973 at 2506. 
Specifically, AstraZeneca allegedly marketed Seroquel for unapproved uses. See id. "Under 
the Food, Drug and Cosmetic Act, a company must specify the intended uses of a product in 
its new drug application to the FDA. Before approving a drug, the FDA must determine that 
the drug is safe and effective for the use proposed by the company. Once approved, the drug 
may not be marketed or promoted for off-label uses." !d. The allegations also included 
"between January 2001 through December 2006, AstraZeneca promoted Seroquel to 
psychiatrists and other physicians for certain uses that were not approved by the FDA as safe 
and effective (including aggression, Alzheimer's disease, anger management, anxiety, 
attention deficit hyperactivity disorder, bipolar maintenance, dementia, depression, mood 
disorder, post-traumatic stress disorder, and sleeplessness)." Id. 
10 !d. 
II See id. As part of the $520 million settlement the federal government received 
$301,907,007 from the civil settlement, state Medicaid programs and the District of Columbia 
will share up to $218,092,993 of the civil settlement. See id. Additionally, AstraZeneca was 
already under a Corporate Integrity Agreement with the Department of Health and Human 
Services. See id. 
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to resorts to "advise" AstraZeneca managers on unapproved uses of the 
drug. 12 
Maryland was rocked by one of the more gruesome tales of health care 
fraud. Dr. Mark Midei, considered one of the top cardiologists in 
Maryland, served as the Cardiology Department Chairman for the St. 
Joseph Medical Center in Towson, Maryland. 13 Dr. Midei joined the 
hospital in January 2008 and conducted a number of heart stent 
procedures on patients. 14 In fact, between January 2008 and January 
2010, when he was relieved of his duties with the hospital, Dr. Midei 
performed at least 2,000 separate procedures. IS In late 2009, the hospital 
received a complaint from one of Dr. Midei's patients, who also was a 
hospital employee. 16 The complaint forced the hospital to review a 
sample of Dr. Midei's cases and what they discovered was astounding. 17 
After reviewing just under 2,000 of the doctor's case, the hospital 
determined that questionable stent placement procedures were conducted 
on nearly 600 patients. 18 Further, the hospital discovered that Dr. Midei 
had evaded notice during various internal reviews because he was 
allowed to submit cases of his choosing for those reviews. 19 In December 
2009, the hospital contacted 585 of the impacted patients and informed 
them that the stent procedure performed on them may have been 
unnecessary.20 In January 2010, the first impacted patient lawsuit was 
filed against Dr. Midei and the hospita1.21 The Maryland state authorities 
launched an investigation, leading to newly proposed laws and 
12 See id. "The United States also contends that AstraZeneca violated the federal Anti-
Kickback Statute by offering and paying illegal remuneration to doctors it recruited to serve as 
authors of articles written by AstraZeneca and its agents about the unapproved uses of 
Seroquel. AstraZeneca also offered and paid illegal remuneration to doctors to travel to resort 
locations to 'advise' AstraZeneca about marketing messages for unapproved uses of Seroquel, 
and paid doctors to give promotional lectures to other health care professionals about 
unapproved and unaccepted uses ofSeroquel. The United States contends that these payments 
were intended to induce the doctors to prescribe Seroquel for unapproved uses in violation of 
the federal Anti-Kickback Statute." Id. 
13 Robert Little, Doctor Evaded Peer Review; Cardiologist Accused of Placing Unneeded 
Stents Also Picked Cases to be Checked, BALT. SUN, May 29, 2010, at AI. 
14 See id. A stent is a flexible mesh tube placed in an artery to ensure the artery remains 
open. See generally Emily Mullin, More Baltimore-area docs may have implanted 
unnecessary stents, lawyer says, BALT. Bus. J., Oct. 5,2010. 
15 Little, supra note 13. 
16 /d. 
17 See id. 
18 Id. "After reviewing 'nearly 2,000' of Midei's cases - a number that hospital officials 
had not disclosed - reviewers found questionable stents in 585 patients, or about every third or 
fourth case." /d. 
19 /d. 
20 Id. 
21 See generally Gary Haber, St. Joseph Medical Center sued Over Stent Implant, BALT. 
Bus. J., Jan. 22,2010. 
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procedures to combat health care fraud. 22 As of October 2010, 101 
individual and single class action lawsuits have been filed in this matter. 23 
Finally, the Maryland Board of Physicians charged Dr. Midei with 
performing unnecessary medical procedures.24 
Congress also increased its commitment to eradicating health care 
fraud. Senator Kristen Gillibrand of New York offered legislation, which 
opined that Medicare and Medicaid fraud cost the United States economy 
more than $80 billion and the taxpayers of New York more than $5 
billion alone?S Spending measures passed by Congress for Fiscal Year 
2011 authorized $1.7 billion to combat fraud, waste, and abuse in health 
care.26 An additional $561 million was added late in the budget season to 
further bolster these activities.27 
The Office of Inspector General for the United States Department of 
Health and Human Services ("OIG") has been busy on these issues as 
well. In Fiscal Year 2010, OIG received civil monetary penalties for 
twenty-three fraud or fraudulent claims cases and fourteen kickback 
cases.28 These cases resulted in over $19 million in civil monetary 
penalties for the OIG in a single year. 29 
It is clear that the government significantly raised the stakes for health 
care providers participating in Federal health care programs. While the 
two examples above are related to large corporations, all entities 
submitting claims to Medicare, Medicaid, and other similar programs are 
vulnerable to attack. Under such intense scrutiny, how can a health care 
provider possibly navigate a new, highly charged environment? 
22 Scott Graham, Md. Health Care Chief Calls for Law. Policy Changes in Response to 
Stents Query, BALT. Bus. J., Sept. 22, 2010. "John M. Colmers, the secretary of the state's 
Department of Health and Mental Hygiene, calls for new laws that would allow Maryland's 
health care agencies to share more information with each other, give Maryland's physicians 
board greater leeway to investigate complaints against providers and slow the flow of some 
information being investigated from being shared with the public." !d. 
23 See Mullin, supra note 14. 
24 ld. 
25 Congo Documents, Gillibrand Announces New Legislation to Reduce and Fraud in 
Medicare and Medicaid, Protect Health Care for Seniors, Save Taxpayers Billions (July 13, 
2010), available at 2010 WLNR 14089959. 
26 Off-Label Marketing Continues as Priority for Federal Fraud Enforcement, FDA Wk., 
Aug. 20, 2010. 
27 ld. $376 million would go to the Centers for MedicarelMedicaid Services program 
integrity activities, $95 million would go the Office of the Inspector General for Health and 
Human Services and $90 million would go to the Department of Justice. See id. 
28 See False and Fraudulent Claims, U.S. DEP'T OF HEALTH & HUMAN SERV.: OFFICE OF 
INSPECTOR GEN., http://oig.hhs.gov/fraudlenforcementlcmp/false_clairns.asp (last visited Nov. 
19,2010); See also Kickback and Physician Self-Referral. U.S. DEP'T OF HEALTH & HUMAN 
SERV.: OFFICE OF INSPECTOR GEN., http://oig.hhs.gov/fraudlenforcement/cmp/kickback.asp 
(last visited Feb. 2, 2011). 
29 See id. 
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This Article discusses a systematic approach to building a compliance 
program which can survive the aggressive prosecution of health care 
fraud. Part I explores the False Claims Act, which is used as the basis to 
prosecute health care fraud. 30 Part II considers the Fraud Enforcement 
and Recovery Act of 2009, which updated the False Claims Act and is the 
basis for intense prosecution.31 Part III examines Corporate Integrity 
Agreements and requirements found in most of those documents.32 
Finally, part IV outlines what a strong compliance program should look 
like.33 Ultimately, this Article concludes that the most effective 
compliance program uses the tools already outlined by the federal 
government to protect the corporation, its executives, and its 
shareholders.34 
1. THE FALSE CLAIMS ACT 
The False Claims Act is the popular title for a series of statutes 
restricting fraudulent activity against the federal government. First, the 
most commonly known provision of the law makes it illegal to present, or 
cause to be presented, fraudulent claims for payment or approval to 
federal government employees or members of the military.35 The law 
makes it illegal to make, use, or cause to be used false records or 
statements material to a fraudulent claim,36 have control or possession of 
government money or property and deliver less than the full amount to 
the government/7 defraud the government by acknowledging receipt of 
government property when the property was not received,38 buy or accept 
a promise to buy government property from an improper source,39 or 
30 See infra Part I. 
31 See infra Part II. 
32 See infra Part III. 
33 See infra Part IV. 
34 See infra Part V. 
35 False Claims Act (Lincoln Law), 31 U.S.C. § 3729(a)(I)(A) (2010) (stating it a federal 
crime for any person who "knowingly presents, or causes to be presented, a false or fraudulent 
claim for payment or approval. .. "). 
36 31 U.S.C. § 3729(a)(l)(8) (stating it is illegal for any person who "knowingly makes, 
uses, or causes to be made or used, a false record or statement material to a false or fraudulent 
claim ... "). 
37 31 U.S.c. § 3729(a)(l)(D) (stating it is unlawful for any person who "has possession, 
custody, or control of property or money used, or to be used, by the Government and 
knowingly delivers, or causes to be delivered, less than all of that money or property ... "). 
38 31 U.S.C. § 3729(a)( I )(E) (stating that the law is violated when a person "is authorized 
to make or deliver a document certifying receipt of property used, or to be used, by the 
Government and, intending to defraud the Government, makes or delivers the receipt without 
completely knowing that the information on the receipt is true ... "). 
39 See id. The law creates a prohibition for anyone who "knowingly buys, or receives as 
a pledge of an obligation or debt, public property from an officer or employee of the 
Government, or a member of the Armed Forces, who lawfully may not sell or pledge property 
.... " ld. 
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commit conspiracy to violate any of the aforementioned provisions.4o 
Any person or entity violating the law was liable for a civil penalty of no 
less than $5,000 or no more than $10,000, plus three times the damages 
incurred by the government.41 Interestingly, a provision in the law 
allowed the ruling court to reduce the treble damages to double damages 
if the person or entity who violated the law notified the government 
within 30 days of obtaining the information, the person or entity fully 
cooperated with the government investigation, and there was not a 
pending legal action already filed.42 
II. FRAUD ENFORCEMENT AND RECOVERY ACT OF 2009 
In response to the financial crisis which began in 2008, Congress 
passed the Fraud Enforcement and Recovery Act of 2009 ("FERA,,).43 
The law, which passed on May 20, 2009,44 made several changes to 
several existing laws. The most substantive overall change amended the 
criminal code to define terms related to the mortgage industry, the 
Troubled Asset Relief Plan, and the securities industry. 45 The most 
important change for the health care industry revolved around two 
changes, though. The False Claims Act was amended to expand liability 
for making false or fraudulent claims to the federal government46 and 
40 See id. 
41 See id. 
42 See id. The law allows this exception when: "(A) the person committing the violation 
of this subsection furnished officials of the United States responsible for investigating false 
claims violations with all information known to such person about the violation within 30 
days after the date on which the defendant first obtained the information; (B) such person fully 
cooperated with any Government investigation of such violation; and (C) at the time such 
person furnished the United States with the information about the violation, no criminal 
prosecution, civil action, or administrative action had commenced under this title with respect 
to such violation, and the person did not have actual knowledge of the existence of an 
investigation into such violation." Id. 
43 Fraud Enforcement and Recovery Act of 2009, Pub. L. No. 111-21, 123 Stat. 1617 (to 
be codified at 31 U.S.C. 3729). 
44 Id. 
45 See id. Specifically, the law amends the federal criminal code to include within the 
defmition of "financial institution" a mortgage lending business or any person or entity that 
makes, in whole or in part, a federally related mortgage loan. Next, it defines "mortgage 
lending business" as an organization that finances or refinances any debt secured by an 
interest in real estate, including private mortgage companies and their subsidiaries, and whose 
activities affect interstate or foreign commerce. Third, it extends the prohibition against 
making false statements in a mortgage application to employees and agents of a mortgage 
lending business. Fourth, applies the prohibition against defrauding the federal government to 
fraudulent activities involving the Troubled Asset Relief Program (T ARP) or a federal 
economic stimulus, recovery, or rescue plan. Fifth, it expands securities fraud provisions to 
cover fraud involving options and futures in commodities. Sixth, it expands the concept of 
monetary proceeds, for purposes of enforcing prohibitions against money laundering, to 
include gross receipts. See id. 
46 See id. 
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applied liability for presenting a false or fraudulent claim for payment or 
approval to anyone, which were previously limited to just federal 
employees and military officers.47 Another addition now requires persons 
who violate the law to reimburse the federal government for the costs of a 
civil action to recover penalties or damages.48 Finally, the new law 
expanded the ability of the government to intervene in qui tam actions 
brought by whistleblowers against companies defrauding the 
government. 49 
III. WHAT IS A CORPORATE INTEGRITY AGREEMENT? 
Even if a health care company is successful in evading liability under 
the False Claims Act, a Corporate Integrity Agreement ("the Agreement") 
may still be necessary to resolve outstanding issues. Corporate Integrity 
Agreements are agreements between the OIG and entities that may have 
been liable for defrauding the government in federal health care program 
transactions such as Medicare and Medicaid.50 These agreements 
generally place nine major requirements on the participant: (1) a 
Compliance Committee; (2) internal audit and review processes; (3) 
developing and implementing a Code of Conduct; (4) developing and 
implementing policies and procedures; (5) developing and implementing 
training; (6) retaining an Independent Review Organization; (7) 
developing and implementing an Employee Disclosure Program; (8) 
screening and removing ineligible persons; (9) and filing incremental 
reports.51 Please note that Corporate Integrity Agreements are intricate 
documents containing extensive boilerplate language. This Article takes 
a high level view of the standard document and is clear that there may be 
unique requirements or language in some documents. 
A. Compliance Officer/Compliance Committee 
One of the first requirements discussed in a Corporate Integrity 
Agreement is a Compliance Committee. First, the Agreement calls for a 
defined Compliance Officer position, with specified responsibilities, 
47 Compare 31 U.S.C.A. § 3729(a)(1) (2009) ("Any person who knowingly presents, or 
causes to be presented, a false or fraudulent claim for payment or approval .... "), with 31 
U.S.C.A. § 3729(a)(1) (2008) ("Any person who knowingly presents, or causes to be 
presented, to an officer or employee of the United States Government or a member of the 
Armed Forces of the United States a false of fraudulent claim for payment or approval .... "). 
48 See Fraud Enforcement and Recovery Act § 4(a)(3), 123 Stat. at 1622. 
49 See id. 
50 Corporate Integrity Agreements, U.S. DEP'T OF HEALTH AND HUMAN SERV., OFFICE OF 
INSPECTOR GEN., http://oig.hhs.gov/fraudlcias.asp (last visited Nov. 9,2010). 
51 Corporate Integrity Agreement Between the Office of the Inspector General of the 
United States Department of Health and Human Services and A&C Health Care Services, 
Inc., U.S. DEP'T OF HEALTH AND HUMAN SERV., OFFICE OF INSPECTOR GEN., 1 (Jan. 4,2008), 
http://oig.hhs.gov/fraudlcia/agreements/a_c_health_care_services_inc_Ol042008.pdf. 
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including: developing and implementing policies and procedures, being a 
member of senior management, making reports directly to the Board of 
Directors, being authorized to report any issue directly to the Board of 
Directors, and requiring superiority over the General Counsel or Chief 
Financial Officer. 52 Second, the Agreement calls for the creation of a 
Compliance Committee and affirmative action by the Board of Directors, 
which may include forming a standing committee or passage of a 
reso1ution.53 Finally, these actions all must be achieved within a stated 
timeframe, usually within 120 days of execution of the Agreement. 54 
B. Internal Audit and Review Processes 
Another major requirement of the Agreement requires signatories to 
develop and implement an internal auditing process. 55 Generally, the 
internal audit process examines quality of care issues, whether policies 
and procedures are followed, and whether training offered to staff and all 
obligations of the Agreement are being met. 56 This requirement usually 
must be implemented within 90 days. 57 
C. Developing and Implementing a Code of Conduct 
Third, signatories are required to develop and implement a Code of 
Conduct. 58 The Code of Conduct, at a minimum, must reflect the 
company's and employees' willingness to comply with federal health 
care program requirements; employee obligations and rights under the 
Employee Disclosure Program; and consequences of an employee's 
failure to report. 59 The Agreement also requires all employees to certify 
in writing that they have received, read, understood, and will abide by the 
52 See, e.g., Corporate Integrity Agreement Between the Office of the Inspector General 
of the United States Department of Health and Human Services and Boston Scientific 
Corporation, OFF. OF THE INSPECTOR GEN., U.S. DEP'T OF HEALTH AND HUMAN SERVICES, 4-5 
(2009), http://oig.hhs.gov/fraud/ciai agreementlboston _scientific_corporation _12232009 .pdf 
(last visited Nov. 8,2010). 
53 See id at 5. 
54 See id. 
55 See, e.g., Corporate Integrity Agreement Between the Office of the Inspector General 
for the United States Department of Health and Human Services and Cathedral Rock 
Corporation, et. al. , U.S. DEP'T HEALTH AND HUMAN SERV., OFF. OF THE INSPECTOR GEN., 4 
(2010), http://oig.hhs.gov/fraud/ciaiagreements/cathedra1Jock_01062010.pdf (last visited 
Nov. 8,2010). 
56 See id at 4-5. 
57 See id at 4. 
58 See, e.g., Corporate Integrity Agreement Between the Office of the Inspector General 
for the United States Department of Health and Human Services and Interdent, Inc., et. al., 
U.S. DEP'T HEALTH AND HUMAN SERV., OFF. OF THE INSPECTOR GEN., 4 (June 20, 2008), 
http://oig.hhs.gov/fraud/ciaiagreements/InterDenUnc _ 06202008.pdf (last visited Nov. 8, 
2010). 
59 See id at 4-5. 
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Code of Conduct. 60 In most Agreements, this requirement must be 
implemented within 90 days of execution. 61 
D. Develop and Implement Policies and Procedures 
Fourth, the Agreement requires the development and implementation 
of policies and procedures.62 These policies and procedures must discuss 
the issues covered in the Code of Conduct, the operation of the 
company's compliance program, compliance with federal health care 
programs, the restriction against hiring or contracting with excluded 
persons or entities, and any other issues which initially led to the 
Agreement.63 The required policies and procedures usually must be 
implemented within 90 days of execution. 64 
E. Develop and Implement Staff Training 
Fifth, the Agreement requires the signatories to implement training for 
all staff, Executives, and the Board of Directors.65 The training is split 
into two separate categories: General and Specific.66 Generally, the 
General Training is an hour in length and covers the Agreement 
requirements, the signatory's Compliance Program, and the issues which 
led to the Agreement.67 General Training must be offered to all staff 
including management and the Board of Directors, usually within 90 or 
120 days of execution, and requires written certification from each 
trainee.68 Specific Training is technical in nature and for a smaller 
universe of employees.69 Specific Training discusses in-depth federal 
health care program issues, relevant policies and procedures, and business 
60 Id. at 5. 
6) Id. at 4-5. 
62 U.S. DEP'T HEALTH AND HUMAN SERV., Corporate Integrity Agreement Between the 
Office of the Inspector General for the United States Department of Health and Human 
Services and Grant Park Nursing Home Limited Partnership d/b/a Grant Park Care Center 
and Grant Park Management, LLC, OFF. OF THE INSPECTOR GEN., U.S. DEP'T OF HEALTH AND 
HUM. SERVICES 5 (2008), http://oig.hhs.gov/fraud/ciaiagreements/grant-park_08292008.pdf 
(last visited Feb. 2,2011). 
63 Id at 6-8. 
64 Id at 5, 9. 
65 U.S. DEP'T HEALTH AND HUMAN SERV., Corporate Integrity Agreement Between Office 
of Inspector General for the Department of Health and Human Services and Jazz 
Pharmaceuticals, Inc., OFF. OF THE INSPECTOR GEN., U.S. DEP'T OF HEALTH AND HUM. 
SERVICES 5 (2007), http://oig.hhs.gov/fraud/ciaiagreements/Jazz%20CIA.pdf (last visited Feb. 
2,2011). 
66 Id. 
67 !d. 
68 !d. 
69 Id. 
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specific issues.7o Specific Training must be implemented within 90 days 
of execution and also requires written certification from each trainee. 71 
F. Retain an Independent Review Organization/Monitor 
Signatories are required to retain an Independent Review Organization 
("IRO,,).72 The IRO must be an accounting, auditing, or consulting firm 
and have expertise in billing, coding, reporting, and at least the general 
requirements of federal health care programs.73 The IRO is required to 
evaluate and analyze the signatory's coding, billing, federal health care 
program claims submission and reimbursements. 74 The evaluation and 
analysis exercise is heavily scripted in the Agreement, and at least in the 
first year, the IRO must also complete an analysis of whether the 
signatory sought certain unallowable costs over the course of the year. 75 
G. Develop and Implement an Employee Disclosure Program 
A sixth major requirement under the Agreement is for the signatory to 
develop and implement an Employee Disclosure Program. 76 The 
Employee Disclosure Program is composed of a mechanism to allow an 
employee to disclose to someone other than the employee's chain of 
command, issues or questions related to potential criminal, civil, or 
administrative violations of Medicare or Medicaid statutes and 
regulations.77 The program must develop and implement a policy 
emphasizing that employees will not face retaliation or harassment for 
disclosing potential violations.78 Additionally, the program must allow 
for anonymous disclosure communications and be implemented generally 
within 90 days.79 Finally, the Agreement obligates the Compliance 
70 Id. 
71 See OFF. OF THE INSPECTOR GEN., U.S. DEP'T OF HEALTH AND HUM. SERVICES, supra 
note 65. 
72 U.S. DEP'T HEALTH AND HUMAN SERV., Corporate Integrity Agreement Between Office 
of Inspector General for the Department of Health and Human Services and Kohal Pharmacy, 
Inc., OFF. OF THE INSPECTOR GEN., U.S. DEP'T OF HEALTH AND HUM. SERVICES 5 (June 21, 
2007), http://oig.hhs.gov/fraudlcialagreements/kohat-.Phannacy_inc _ 06212007.pdf (last 
visited Feb. 2,2011). 
73 Id. 
74 Id. 
75 Id. 
76 U.S. DEP'T HEALTH AND HUMAN SERV., Corporate Integrity Agreement Between Office 
of Inspector General for the Department of Health and Human Services and MA. C. T. Health 
Board, Inc., OFF. OF THE INSPECTOR GEN., U.S. DEP'T OF HEALTH AND HUM. SERVICES 5 
(2007), http://oig.hhs.gov/fraudiciaiagreementsIMACT_health_board_incI21 72007.pdf (last 
visited Feb. 2, 2011). 
77 Id. 
78 Id. 
79 Id. 
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Officer to maintain disclosure logs and make a good faith effort to 
investigate all disclosures.8o 
H. Screen and Remove Ineligible Persons 
A seventh major requirement in the Agreement centers on ineligible 
persons.8! The Agreement defines ineligible persons as anyone currently 
debarred, suspended, or excluded from participating in federal health care 
programs or who has a pending conviction for fraud that had not yet 
resulted in debarment, suspension, or exclusion.82 The Agreement 
requires the signatory to ensure all employees are not ineligible, that they 
are screened against the two federal ineligibility databases, and 
implement a policy requiring employees to disclose debarment, 
exclusion, or suspension immediately.83 The Agreement finally requires 
the removal of any ineligible person from participating in or around 
federal health care programs attached to the signatory. 84 In most cases, 
this must be implemented within 90 days of execution. 85 
IV. INCREMENTAL REpORTING 
The eighth and final major requirement is the submission of 
incremental reports.86 Specifically, the signatory must submit an 
Implementation Report within six months of execution that outlines 
progress against Agreement obligations to that point. 87 Within 14 months 
of execution, an Annual Report must be submitted to the OIG with 
specified information and statistics.88 Subsequently, Annual Reports are 
due on the anniversary of the original Annual Report due date. 89 
80 Id. 
81 See U.S. DEP'T HEALTH AND HUMAN SERV., Corporate Integrity Agreement Between 
Office of Inspector General for the Department of Health and Human Services and McAllen 
Hospitals. L.P. d/b/a South Texas Health System, (2009), 
http://oig.hhs.gov/fraud/cia/agreements/marshaIl_ fire "'protection _district_ambulance_and_ 
rescue_service_03312008.pdf(last visited Feb. 2,2011). 
82 Id. 
83 Id. 
84 Id.atI7. 
85 Id. 
86 See U.S. DEP'T HEALTH AND HUMAN SERV., Corporate Integrity Agreement Between 
Office of Inspector General for the Department of Health and Human Services and Marshall 
Fire Protection District Ambulance and Rescue Service, (2008) 
http://oig.hhs.gov/cia/agreements/marshaIl_fire "'protection _district_ambulance _and Jescue_ 
service_03312008.pdf(last visited Feb. 2, 2011). 
87 Id. 
88 Id at 18-20. 
89 Id at 20-21. 
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V. How CAN A HEALTH CARE COMPANY IMMUNIZE ITSELF IN THIS NEW, 
AGGRESSIVE ENVIRONMENT? 
Before discussing a defensive strategy, there are two important 
assumptions that have to be made. First, how serious is the company 
about compliance? Compliance programs take organization, dedication, 
and resources. If a company has a half-hearted approach to implementing 
compliance efforts and does not provide the necessary supports, it may 
create the perception that any questionable behavior was purposeful. The 
second assumption is that an organization is not obligated under an 
existing settlement agreement with either a public or private entity which 
dictates the elements of a compliance program. 
It is my belief that utilizing the government's existing response to 
health care fraud is the best defense to aggressive prosecution. 
Specifically, by dissecting standard Corporate Integrity Agreement 
requirements and implementing some provisions in advance as part of an 
overall compliance strategy, a health care company can somewhat 
immunize itself from fraud allegations and the expense accompanying 
investigations and settlements. Further, I believe there are five specific 
areas of the Corporate Integrity Agreement that can be the anchor for a 
good compliance program: the Compliance Officer, developing and 
implementing an Employee Disclosure Program, training, screening 
process for ineligible persons, and internal and external audit processes. 
A. Hire a Professional Compliance Officer 
Virtually every Corporate Integrity Agreement requires a participating 
entity to hire a Compliance Officer and/or Compliance Committee. 90 
Under the Corporate Integrity Agreement, the Compliance Officer is 
responsible for assessing risk, implementing policies and procedures, 
monitoring internal and external audits, and reporting to the Executive 
Committee, Board of Directors, and Health and Human Services.91 
There are many different position descriptions for a Compliance 
Officer. However, ideally, I believe there are six important job 
responsibilities. First, the position should have unfettered access to all 
aspects of the corporation. Second, the position should review all 
policies and procedures and make recommendations for modifications or 
improvements. Third, the position should be responsible for all 
investigations and recommendations related to policy and procedure 
violations. Fourth, all compliance education and training should be 
vested in the position. Fifth, the Compliance Officer should not have any 
90 See U.S. DEP'T HEALTH AND HUMAN SERV., Corporate Integrity Agreements Document 
List, OFF. OF THE INSPECTOR GEN., U.S. DEP'T OF HEALTH AND HUM. SERV., 
http://oig.hhs.gov/fraud/cialcia_list.asp (last visited Feb. 2, 2011). 
91 See supra note 52 and accompanying text. 
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duties other than compliance. There is a lengthier discussion on this 
subject later in this section.92 Finally, the position should issue quarterly 
reports to the Executive Committee and the Board of Directors on 
compliance issues and risk assessments. 
Next, who fills the position and to whom do they report? In many 
corporations, the Compliance Officer is the General Counselor the Chief 
Financial Officer.93 There are a few problems with another member of 
the executive staff undertaking the duties of a Compliance Officer. First, 
an executive staff member already has significant responsibilities and 
obligations. Managing a compliance program is a full-time job all unto 
itself. One issue the government could easily raise in investigating a 
Corporate Compliance Program is that the program, as implemented by 
the company, is not a priority because it is simply rolled into another 
corporate function. 
A second, larger issue is a question of independence and objectivity. 
Specifically, the General Counsel has an attorney-client relationship with 
the corporation and generally serves in an advisory capacity.94 Imagine 
that General Counsel advises the corporation against implementing a 
policy, which may negatively impact its compliance with federal health 
care law. Subsequently, the General Counsel is expected to implement 
said policy, measure compliance, and then possibly defend the 
corporation in an investigation. Obviously, such a real scenario raises a 
number of ethical and legal issues. 
The situation does not look more promising for the Chief Financial 
Officer. Imagine the Chief Financial Officer implements a financial 
policy which negatively impacts the corporation's compliance with 
federal health policies and regulations. The corporation lacks an 
independent voice to question the legality of the policy implementation. 
92 See infra notes 94-95 and accompanying text. 
93 JONATHAN SMITH & CO., http://www.jonathansmith.comlanne.cfm (last visited Nov. 6, 
2010) (Jonathan Smith merges Chief Compliance Officer and Chief Financial Officer); 
MEDQUIST, http://www.medquist.com!Default.aspx?tabid=132 (last visited Nov. 6, 2010) 
(MedQuist merges Chief Compliance Officer and General Counsel); NAVIGATORS GROUP, 
INC., http://www.navg.comlPages/mngmnt-team-detail.aspx?EmpId=102 (last visited Nov. 6, 
2010) (Navigators Group merges Chief Compliance Officer and General Counsel); REDWOOD 
INVESTMENTS, http://www.redwoodinv.comlRedwood_Investments/Steven_T._Flammey.html 
(last visited Feb. 2, 2011) (Redwood Investments merges Chief Compliance Officer and 
General Counsel). 
94 See MODEL RULES OF PROF'L CONDUCT R. 1.13 (2007); RESTATEMENT (THIRD) OF THE 
LAW GOVERNING LAWYERS § 96 (2000). The Restatement and the model code, while not 
binding on any jurisdiction, each serve as persuasive models of the rules of ethics which have 
provided guidelines and advice for states in the creation and interpretation of their ethical 
codes. There is little case law, controlling on a national scale, the scope of the attorney and 
corporation-client privilege as the interpretation of state ethical codes is left to the states 
themselves. Cf Upjohn Co. v. U.S., 449 U.S. 383, 389 (1981) (holding that the scope of 
corporation's privilege decided on the grounds of federal common law). 
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This would raise a red flag for any investigator. Based on those 
arguments, the Compliance Officer should be an independent employee. 
The next step is to determine the reporting chain for the Compliance 
Officer. Based on the previous argument, it does not make legal or 
practical sense for the Compliance Officer to report to the General 
Counselor the Chief Financial Officer. Most other executive staff 
members would have similar conflicts as the General Counselor the 
Chief Financial Officer because of their eXIstmg day-to-day 
responsibilities. Thus, the best option would be for the position to not be 
an executive member of the organization, but report directly to the Chief 
Executive Officer and/or the Board of Directors. The Executive 
Committee is vested with issues like profitability, which should not be 
within the Compliance Officer's scope. Further, a strong argument could 
be made that the Compliance Officer should report to the Board of 
Directors because they are not involved in the day-to-day management of 
the business. Regardless, the Compliance Officer should report to the top 
of the corporation's management. 
A strongly defined, independent Compliance Officer is evidence that a 
corporation takes the compliance function seriously and is the first 
element of a strong compliance program. If the Compliance Officer is in 
a weakened position, it stands to reason that the program the individual 
manages would also be perceived as weak. 
B. Develop and Implement an Employee Disclosure Program 
Another provision in Corporate Integrity Agreements calls for the 
development and implementation of an Employee Disclosure Program. 95 
An Employee Disclosure Program is a policy and procedural mechanism 
for employees to report what they believe is illegal or immoral behavior 
within the organization.96 These programs also protect employees who 
make disclosures against any form of retaliation by the corporation such 
as harassment or demotion. Also, under a Corporate Integrity 
Agreement, the Compliance Officer is required to develop and maintain a 
log of complaints, which records the complaint, the reporting source, and 
the disposition of the complaint.97 The Compliance Officer also 
coordinates the investigation of each complaint. The reporting 
mechanism must be advertised openly and liberally to all employees. 
Finally, a list of reporting outlets must be made available to employees, 
usually beyond their chain of command. These sources usually include 
the Compliance Officer, the State Inspector General, and the OIG. 
95 See supra text accompanying note 76. 
96 See supra text accompanying note 77-79. 
97 See supra text accompanying note 80. 
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Developing and implementing an Employee Disclosure Program is a 
key component in a corporation's defense strategy. Many qui tam 
plaintiffs tell the same story. They observed wrongdoing of some sort in 
the workplace and reported it to their supervisor or someone else in their 
chain of command. Once they reported it, they were either ignored or 
haras~ed for disclosing the acts in question. While developing such 
mechanisms is seemingly uncomfortable for many corporations, the 
rationale for such a program is simple. The simple answer is that it may 
cost the corporation and may have significant ramifications. If a 
corporation has nothing to hide, it would be ideal to have every employee 
invested in protecting the corporation from malfeasance. Imagine a 
manager in a nursing home had an agreement with a respiratory therapist 
whereby the respiratory therapist would submit claims to Medicare, but 
would not actually provide service to the patients. The manager agreed to 
verify the services as part of the nursing home's treatment plan for its 
patients. Imagine further a subordinate discovered the deception and 
failed to disclose because the employee feared for his job. Finally, 
consider a patient who actually needed respiratory therapy is denied the 
service because of the deceptive agreement between the respiratory 
therapist and the manager. The level of liability and risk for the 
corporation in the scenario is grave. In any investigation, it will be clear 
that the failure to disclose may have been remedied ifthe employee could 
have disclosed against the manager. 
How would the Employee Disclosure Program be implemented? First, 
I would suggest hiring a third party vendor to provide an external 800 
telephone number and to actually log disclosures. After logging the 
disclosures, the vendor would forward all the relevant information to the 
Compliance Officer for investigation and disposition. Utilizing such a 
vendor would inspire confidence in the system and ensure the recording 
of the information is uncompromised. The Disclosure Program policies 
should be clear as to all of the steps of the investigation, report 
generation, and disposition of a disclosure. The policy should also 
outline the process for ensuring the discloser is protected from any form 
of disciplinary action for disclosing. Finally, the policies must be 
communicated in a clear and concise manor in every form and medium 
available to the corporation. This includes email, open forums, posters, 
announcements, and presentations at staff meetings and phone trees. It is 
important that all modes of communication are used because a logical 
question during a False Claims Act investigation may be how were 
employees alerted about the Disclosure Program. The ability to show 
constant communication about the Disclosure Program may prove to be 
invaluable. If one believes the philosophy that the best defense is a good 
defense, the use of a Disclosure Program is a custom made support. 
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C. Training 
Compliance training for all employees is the next provision in the 
strategy.98 As previously noted, Corporate Integrity Agreements require 
participants to offer training to all employees. 99 Building a solid 
compliance program requires a competent training program. 
So, what kind of training is needed? All employees should be trained 
on the company's overall compliance program, the False Claims Act, 
Employee Disclosure Program, and the consequences of being an 
excluded person. Training should be held at least on an annual basis and 
also be encompassed in any new employee orientation. 
For those employees in claims reimbursement positions, it is critical 
that they receive the above-referenced training as well as Medicare and 
Medicaid training. Given the intense scrutiny that claim submissions are 
receiving from the Centers for Medicare and Medicaid Services, it is 
crucial that this training be offered on a quarterly basis. Part of the 
strategy articulated in this Article is predicated on building a compliance 
program that is risk adverse. 
Who should offer the training and how should it be delivered? 
Seemingly, there is no need to bring in specialized consultants or trainers. 
This Article has advised hiring a professional Compliance Officer, and 
that individual can train the staff. Also, it is an excellent opportunity to 
acquaint the staff with the Compliance Officer and allow them to ask 
questions. As for delivery, there are many available options including 
online training. What is most important is that training is offered and 
made mandatory for the staff. 
D. Screening of Ineligible Persons 
Corporate involvement of an ineligible person in a health care 
company will inspire investigations by the OIG or the Department of 
Justice. As noted above, once a company is under a Corporate Integrity 
Agreement, it is restricted from allowing any ineligible individual from 
working on behalf of the company in or around federal health care 
programs. 100 
The company should screen all employees and contractors to ensure 
that they are not ineligible persons. Someone who is deemed ineligible 
has already been involved in fraud or other malfeasance and could 
compromise the company. It is important to note that contractors, 
regardless of the service provided on behalf of the company, create as 
much risk for the company as an employee and should not be treated any 
98 See supra text accompanying notes 65-71. 
99 See supra text accompanying note 68. 
100 See supra text accompanying notes 81-85. 
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differently. These screenings should happen at least on an annual basis 
and during the pre-hire process. 
In addition, the company should also implement policies which 
require all employees and contractors to notify the company if they are 
ever served a Notice of Exclusion. Imagine a nurse is employed in a 
hospice. While working there, she is implicated in a Medicaid fraud 
scheme. Before the matter is settled, the nurse quits her job and takes a 
job working in an urgent care clinic. Under the scenario, assume the 
urgent care clinic screens all employees for ineligibility during the pre-
hire process and on an annual basis. During her pre-hire process, the 
nurse was screened for ineligibility, but was not implicated because the 
matter was still pending. Six months after starting her employment with 
the urgent care clinic, the matter is resolved and, as a result, the nurse is 
served a Notice of Exclusion. If the urgent care clinic did not know the 
nurse was excluded, she would continue working, unabated, for six 
months until the next round of screenings were conducted. The scenario 
merely underscores why the policy is essential. 
Also, it is pivotal that regardless of an individual's position within a 
company, they must be screened and, if they are found to be ineligible, 
removed or activities highly restricted. It is not uncommon for owners or 
executives of health care companies to be implicated in malfeasance and 
then excluded. 101 These individuals either start companies under new 
names or simply move on to another company. \02 Regardless of the 
position the individual holds with the company, they are still excluded 
and their activities must be carefully managed or the company risks 
extreme exposure. 
E. Internal and External Audit Processes 
The final defensive strategy is to have strong internal and external 
audit processes. First, the company should implement a robust internal 
audit process. Depending on the company's size, the internal audit 
should be conducted at least quarterly and result in a written report 
summarizing the audit sample, the findings, and recommendations for 
improvements. As described earlier, the Compliance Officer should be 
designated coordinator for the audit. Additionally, there should be a 
management response to the report which clearly and concisely responds 
to the audit's findings. 
The external audit process should mirror the internal process and be 
conducted on at least an annual basis. Just as with the internal audits, the 
external audits should result in a final report which includes a 
101 See Markon, supra note 5, at 2. 
102 Cj OFF. OF THE INSPECTOR GEN., MEDICARE PAYMENTS TO OIG EXCLUDED PHYSICIANS 
1-2 (2000). 
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management response to each finding. While it may seem obvious, the 
credentials of the auditing firm must be above reproach. It is important to 
note that the credibility of the audit rests on the credibility, independence, 
and objectivity of the auditors. 
VI. CONCLUSION 
In April 2010, the Maryland General Assembly, in concert with the 
Office of the Governor and Maryland Hospital Association, passed the 
Maryland False Claims Act ("MFCA,,).103 The act mirrors similar 
regulations at the federal level introduced originally by the federal False 
Claims Act, which are discussed at length above. I04 With the passage of 
MFCA, Maryland has joined several other states in recognizing that 
fighting health care fraud at the federal level has its limits, in that only 
larger, more global cases are usually prosecuted.105 These state acts, like 
the MFCA, empower state regulatory agencies with the necessary tools to 
fight fraud at a more localized level. I06 The passage of the MFCA is 
expected to increase the recovery of Medicaid Funds that were lost to 
fraud, waste, or cost recoveries to as much as $46.5 million in fiscal year 
2011, an increase of nearly 75% over the current year's estimate of$26.5 
million.107 Beyond granting expressed powers and procedures for state 
agencies in prosecuting fraud, the MFCA provides explicit whistleblower 
protections to employees and requires employers to conspicuously 
provide notice ofthose protections to all employees. 108 
The federal government has also made it clear that it intends to 
become an aggressive player as it relates to health care fraud. 109 Under 
such intense scrutiny, a health care company must take a proactive 
approach to protect itself. The keys to developing a protection strategy 
can be found in the Corporate Integrity Agreements entered into by 
companies and individuals who have run afoul of the Department of 
Health and Human Services. There are five particular actions a company 
can take to protect itself: hire a professional, independent Compliance 
Officer, develop and implement an Employee Disclosure Program, 
training, screening for ineligible persons, and internal and external audit 
103 Maryland Register Notice ofSB 279, in April of201O. 
104 Office of the Lt. Governor Anthony G. Brown, Press Release: Maryland False Health 
Claims Act of 2010 Passes Final Vote in Maryland General Assembly, April 9, 2010, 
http://www.govemor.maryland.gov/ltgovemor/pressreleases/ I 00409 .asp. 
105 Id. 
106 Id. 
107 Department of Health and Mental Hygiene, Press Release: Lt. Governor Brown 
Announces More than $26 Million Recovered in FY2010 from Medicaid Fraud, Waste and 
Abuse, July 22, 2010, http://www.dhmh.state.md.us/pressreleases/201O/ltgov07221O.html. 
108 MARYLAND CODE ANN., HEALTH-GEN. §§ 2-607-2-608. (2010). 
109 See supra notes 7-12 and accompanying text. 
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processes. If a health care company shows dedication to a robust 
compliance program, it can weather the gathering storm of fraud 
prosecution. 
